Micropep, a Boston, MA-based company which specializes in micropeptide technology, raised $29M in Series B funding.
The round was led by Zebra Impact Ventures, and BPI Green Tech Investment. Existing investors, Fall Line Capital, FMC Ventures, Sofinnova Partners, Supernova Invest, and IRDI Capital Investissement also participated.
The company intends to use the funds to accelerate go-to-market strategy through partnerships, complete the regulatory studies of the first biofungicide molecule, and expand its pipeline of micropeptide active ingredients on the Krisalix™ platform.
Led by CEO Thomas Laurent, Micropep Technologies, with operations in the US and France, is a global leader in breakthrough micropeptide technology. The company has developed a proprietary AI-powered discovery platform for micropeptides, which are short protein molecules naturally produced by plant cells and have an infinite number of applications. It is building natural solutions addressing global challenges in multiple markets, with a key focus in agriculture.
FinSMEs
25/07/2024